Ingmar Hoerr, PhD, MBA, is the Chairman of the Supervisory Board of CureVac AG. He founded the biopharmaceutical company in 2000 together with colleagues in Tuebingen, Germany. Today, CureVac is one of the few "unicorn" life sciences companies from Germany. The company is currently valued at Euro 1.5 billion. Since Dr. Hoerr founded CureVac, he raised approximately $430 million (€400 million) in equity investments.
View Event →